This article explores how starting materials, specifically producer cell lines and the design of transfer plasmids, affect the quality attributes of AAV vectors.
Stanley Capital Partners announces its portfolio company, Laboratoire X.O, has completed the acquisition of the prescription drug Nimodipine under the brand name Nimotop from Bayer for several markets globally excluding mainland China.
As 2023 draws to a close and companies finalise their Regulatory and Quality budgets for 2024, Arriello’s Kate Coleman assesses the trends topping the strategic agenda.
Julie Neal, Director at management consultancy, Vendigital, and Dr. Ulli Waltinger, Vice President specialising in AI and IoT at Siemens Advanta explore Life Sciences: A Data-Led Approach to Sustainability Transformation.
LyoFlow is a disruptive and patented solution based on a new PAT tool for Real Time Mass Flow Rate measurement during primary drying of a lyophilisation process.
Medicann, the award winning medicinal cannabis clinic is launching the first clinic in Ireland, and are now accepting patients who wish to know if they are eligible for treatment.
ASA Spezialenzyme GmbH has selected an FP50 from Flexicon Liquid Filling, part of Watson-Marlow Fluid Technology Solutions (WMFTS), for filling and stoppering vials in the microlitre range.
Nataliya Andreychuk, the co-founder and CEO of Viseven, reveals her personal battle against breast cancer. Her story is a testament to enduring strength, tenacity, and sincere commitment to make a genuine difference in patients’ lives.
In this article, Ross Errington, Head of Drug Product Development at Recipharm, explores the growth of the biosimilar market and its role in driving the demand for biologic redevelopment, focusing on the move towards inhaled biologics as a solution.
The biopharma industry has made minor strides toward improved resilience, but it’s not enough to meet future global demand for novel therapeutics. However, Ludovi Brellier, shows how to get there.
